340B: 266 House Legislators Want Fines for Drug Companies
Two hundred sixty-six members of the House of Representatives have told the Department of Health and Human Services that HHS should fine drug companies that deny 340B discounts to hospitals for drugs dispensed by contract pharmacies and to make drug companies pay hospitals back for discounts that were withheld. The letter says it’s the long-held position of the Health Resources and Services Administration that drug companies must provide 340B discounts to hospitals and clinics that qualify, regardless of whether hospitals dispense the drugs themselves. The letter states there are no provisions in the statute that allow manufacturers to set conditions or impede access to 340B discounts.
email article
Making the pandemic s emergency suspension of Medicare s telehealth rules permanent got overwhelming support at a virtual hearing of the House Committee on Energy and Commerce s health subcommittee on Tuesday.
Members touted their bipartisan appreciation for what the technology has done and can yet do for healthcare. It s time to make Medicare reimbursement for telehealth permanent, said subcommittee chairwoman Anna G. Eshoo (D-Calif.) in opening the hearing. Telehealth isn t the silver bullet for the deeper problems that exist in our healthcare system, but it s demonstrated great promise for high quality, innovative care if we intentionally create legislation that fits our nation s needs.